Synergy Health plc 46 Annual Report & Financial Statements 2010 Remuneration report Composition of the Remuneration Committee Incentive arrangements The Remuneration Committee of the Board is chaired by D K Nichol and Annual bonus scheme also comprises the non-executive directors, S G Wilson and R E Lerwill.
The executive directors participate in the Groups performance-related When appropriate, the Committee also invites the views of the Chief annual bonus scheme.
Bonuses are currently awarded for achieving Executive, the Group Finance Director and the Group Company Secretary.
pro t and cash ow targets set by the Board, together with a smaller element related to achieving the Groups strategic objectives during the Remuneration policy year.
The executive directors are entitled to receive their full bonus if all The Group is committed to meeting best practice in areas of corporate of these objectives have been achieved.
Maximum potential bonuses, as governance and executive remuneration.
The Companys executive a percentage of base salary, were 75% in respect of R M Steeves, 55% remuneration policy is in line with the Companys overall practice on in respect of I M Jacques and 30% in respect of M L M Smit.
This is to reward employees competitively, taking into payments are pensionable.
account performance and market comparisons.
In setting executive salaries, the Committee takes into account a number of factors, including The Board aims to achieve a balance between short-term targets that are market conditions, salaries in comparable companies in similar industries, rewarded by an annual cash bonus payment and longer term targets that and affordability, in order to attract and retain competent executives.
are rewarded by share-based incentives.
Remuneration is considered with regard to personal performance, responsibilities and experience and this is benchmarked alongside Long-Term Incentive Plan LTIP independently compiled salary survey information.
The Long-Term Incentive Plan for executive directors and senior executives was approved by shareholders in 2005.
The principal features The Committee recognises the need to link an executives remuneration are as follows: package to individual and corporate performance and considers it has achieved a balance between basic salary, annual bonuses, to reward All executive directors and senior executives nominated by the individual performance during the year and share options and long-term Committee are entitled to be considered for the grant of awards under incentive plans to encourage longer term career planning within the the LTIP.
The awards take the form of an option over shares, where Group and future participation in its growth.
granting the option is conditional upon the performance of the Company over the measurement period.
The Committee does not consider that the targets that are included in an executives remuneration package are incompatible with a directors The performance conditions were chosen because the Committee responsibility for environmental, social and governance matters.
believes that these targets are aligned and compatible with the interests Whilst the Committees terms of reference do not require speci c targets of shareholders and the creation of shareholder value.
on these matters, the Committee is obliged to ensure that, when setting An award made under the L TIP to a nominated participant will take remuneration policy, appropriate incentives are provided to encourage two forms.
enhanced performance in a fair and reasonable manner.
1 The first type of award is a right to acquire a speci ed number of The details of individual components of the remuneration package and shares by way of an option LTIP option, with award conditional service contracts are disclosed below.
upon the performance of the Company over the measurement period.
The Remuneration Committee has discretion to set the level of conditional Components of executive directors remuneration award up to a maximum of 450% of basic salary.
The initial conditional Overview award granted in June 2005 in respect of R M Steeves and I M Jacques The principal components of executive directors remuneration packages was 450% of basic salary and that of M L M Smit was 150% of basic are base salary, which is the only element of pay on which pension bene ts salary.
The maximum conditional awards for 2006 and 2007 did not are calculated, annual bonus scheme, Long-Term Incentive Plan and exceed 150% of basic salary.
In accordance with the conclusion of the pension bene ts.
Each of these components is explained further below.
Remuneration Committee reported in last years Remuneration report that a conditional award of 200% of basic salary is appropriate for the Salary Chief Executive, a conditional award of 200% of salary was made to The Committee meets at least once a year in order to consider and set the R M Steeves.
Conditional awards of 150% of salary were made to annual salaries for executive directors.
The Committee also reviews the I M Jacques and M L M Smit.
policies adopted regarding remuneration across the Group.
During the year The Remuneration Committee carried out a detailed review of the level the Committee initiated a benchmark exercise to ensure levels of directors of awards under this scheme in July 2009 and adjusted the levels of remuneration were competitive with the market.
The guide adopted was the award so that conditional awards were reduced to 150% of salary the Hewitt New Bridge Street guide for FTSE 250 remuneration for 2009 in respect of R M Steeves and 125% of salary in respect of I M Jacques with the appropriate benchmark for the Company being the FTSE 250 and M L M Smit.
Performance targets were also amended as detailed in bottom half with a median market capitalisation of 375 million.
The Committee considered that in the current economic During the year under review the base salary levels of the Chief Executive conditions the targets needed to be achievable in order to provide the and the Group Finance Director were not increased.
This was in line with necessary motivation for the executive directors.
It should be noted that other Group employees and re ected the need to restrain costs in a the targets remain very demanding, notably that, in order to receive the challenging economic environment.
maximum award relating to the part of the award described in note a below, the earnings per share must grow by 20% on a compound basis over the three-year measurement period.
These changes were made following consultation with the Companys top ten shareholders, who all con rmed that they were supportive of the proposed changes.
Synergy Health plc 47 Annual Report & Financial Statements 2010 The vesting of the shares will be dependent on the extent to which the The number of matching shares will be determined in accordance with the following performance targets have been satis ed: following table: a 50% of the LTIP option is determined by a comparison of the earnings Growth in earnings per share Ratio of matching shares received per share gure at the end of the measurement period with that at Over 15% each year Two shares for each one purchased the start.
For these purposes earnings per share will be adjusted for Between 10% and 15% each year One share for each one purchased amortisation of intangibles, non-recurring items, share option charges and any other items deemed reasonable by the Committee.
Before the end of the financial year the Committee consulted with the b The other 50% of the LTIP option is determined by the Total Companys advisors in view of the changes to UK taxation arrangements Shareholder Return generated by the Company in comparison to coming into effect on 6 April 2010.
Having received appropriate advice that generated by companies in the FTSE 250 Index.
A table ranking and having conservatively estimated the likely level of awards under the the companies in order of performance will be produced each year scheme in June 2010, the Committee amended the rules of the LTIP following the end of the measurement period and the ranking of the scheme to permit the early exercise of awards under the EPS element Company in that table will be established.
Awards in previous years of the LTIP Option and the option under the LTIP co-invest arrangements, used the FTSE Small Companies excluding investment trusts index, subject to a claw back agreement in the event that the option did not vest but the FTSE 250 Index is now considered more appropriate following fully following the completion of the audit of the accounts.
Accordingly, the Companys admission to the Full List in July 2008 and will be used options were exercised by R M Steeves and I M Jacques as described in measuring awards granted from July 2009 onwards.
in the detailed schedules below.
The shares in each element of the conditional award will vest in Pensions accordance with the following table: Executive directors are eligible to participate in the appropriate fide ned contribution pension schemes and other regular employee bene t plans Awards made up to June 2008 including health and life insurance.
The Company makes pension Vesting level EPS growth Position in the TSR table contributions equivalent to 10% of the base annual salary for G Hill Vesting at 100% 25% Top 10% and 15% of the base annual salary for R M Steeves into fide ned Vesting on straight line Between 20% Top 25% but outside contribution schemes.
basis between 50% and 25% top 10% M L M Smit participates in a multi-employer industry-wide fide ned bene ts and 100% scheme.
As the Companys share of the underlying assets and liabilities Vesting on straight line Between 15% Top 50% but outside of the scheme cannot accurately determine the Companys share of the basis between 25% and 20% top 25% overall surplus fide cit of the scheme is treated as fide ned contribution in and 50% nature.
Pension contributions in respect of M L M Smit were equivalent None of the shares Below 15% Below top 50% to 17% of his basic salary.
will vest Service contracts Awards made from July 2009 onwards The Committee has determined that the Companys executive directors Vesting level EPS growth Position in the TSR table are appointed to the Board on terms of a contract that can be terminated by the Company with 12 months notice after the first year of service.
Vesting at 100% 20% Top 25% The Committee believes that this arrangement provides a measure Vesting on straight line Between 15% Top 50% but outside of stability in that it provides an opportunity for the recruitment of basis between 50% and 20% top 25% replacement executives and an orderly hand over of duties.
Contracts on and 100% this basis have been granted to R M Steeves, I M Jacques and G Hill.
Vesting on straight line Between 10% M L M Smits service contract requires six months notice to be given to basis between 25% and 15% the Company and 12 months notice to be given by the Company.
If the and 50% Company serves notice then in addition to such notice M L M Smit is None of the shares Below 10% Below top 50% entitled to compensation of not less then 24 months salary and bene ts, will vest plus the bonus for the previous calendar year.
This clause existed prior to the acquisition of Lips Textielservice Holdings B. V. by the Group by whom 2 The second type of award takes the form of a co-invest arrangement M L M Smit was employed.
and requires that the participant to whom the award is to be made invests The Report of the Directors contains details of directors standing for in shares in the Company and continues to hold those shares throughout election or re-election at the Companys forthcoming Annual General the measurement period LTIP co-invest.
At the end of the measurement Meeting and the unexpired term of their service contracts.
period, depending upon the growth in earnings per share adjusted as above of the Company over the measurement period, the participant will The contract details for the current executive directors are as follows: receive a number of free matching shares under the LTIP co-invest.
Effective date Unexpired term Notice period The maximum amount that a participant may invest is the bonus achieved R M Steeves 1 November 1999 12 months 12 months under the annual bonus scheme during the previous financial year.
G Hill 26 April 2010 12 months 12 months M L M Smit 1 June 1995 12 months See above I M Jacques also had a service contract with 12 months notice on which he gave notice to terminate in November 2009.
It has been agreed that he will be released from his duties and employment no later than 30 June 2010 and that the balance of his contracted salary entitlement will be paid to him at the time of his release.
Synergy Health plc 48 Annual Report & Financial Statements 2010 Remuneration report continued Non-executive directors remuneration The remuneration of non-executive directors is established by the whole Board.
Details of each non-executive directors remuneration are included below.
The non-executive directors do not receive any pension or other bene ts.
All non-executive directors are engaged on letters of appointment that set out their duties and responsibilities and con rm their remuneration.
In the event that either party wishes to terminate the appointment six months notice is required.
The Company may terminate each of these appointments at any time without the payment of compensation other than the notice payment.
The following information has been audited: Directors remuneration The remuneration of the directors, who served throughout the year, for the year to 28 March 2010 is as follows: 2010 Total 2009 Total 2010 2009 Salary Bonus Bene t in kind Excl Pension Excl Pension Pension Pension 000 000 000 000 000 000 000 I M Jacques 242 133 17 392 291 24 24 R E Lerwill 32 32 32 D K Nichol 32 32 32 M L M Smit 235 71 20 326 236 41 37 1 R M Steeves 263 290 10 563 301 181 235 S G Wilson 44 44 44 848 494 47 1,389 936 246 296 1 R M Steeves sacri ced salary and bonus-related emoluments amounting to 123,000 2009: 167,000 which were paid into his pension scheme.
The total directors compensation in relation to other long-term bene ts LTIP and other share-based payments was 745,000 2009: 789,000, calculated in accordance with IFRS 2 Share-based payments.
R M Steeves also served as non-executive Deputy Chairman of CareTech Holdings plc throughout the year.
He received a fee of 39,000 2009: 35,000 for his services.
He resigned from this position in April 2010.
Share options Details of the Companys share option schemes are set out in note 27 to the financial statements.
The following directors hold options over ordinary shares of 0.625p in the Companys share option schemes as follows: Options held at Options granted Options exercised Options held at Exercise price Market value at 29 March 2009 during the year during the year 28 March 2010 pence date of exercise Date from which exercisable Expiry date R M Steeves 1 Sharesave 2,950 2,950 527p 1 February 2015 1 August 2015 I M Jacques 1 Sharesave 1,377 1,377 686p 1 November 2010 1 May 2011 Approved 10,750 4,000 4,000 279p 510p 1 December 2005 1 December 2013 2 scheme 2,750 650p Unapproved 89,250 46,000 279p 510p 1 December 2005 1 December 2010 3 scheme 10,000 497.75p 33,250 650p M L M Smit Unapproved 100,000 25,000 304p 510p 650p 30 July 2006 30 July 2011 3 scheme 75,000 D K Nichol Unapproved 15,000 15,000 326p 650p 27 September 2006 27 September 2011 3 scheme Notes: 1 Sharesave refers to the Savings Related Share Option Scheme.
2 Approved scheme refers to the Approved Share Option Plan.
3 Unapproved scheme refers to the Unapproved Share Option Plan.
Synergy Health plc 49 Annual Report & Financial Statements 2010 Directors interest in Long-Term Incentive Plan shares a LTIP options Maximum number Maximum number Number of options Number of options Maximum number Mid-market share Mid-market share of options as at of options granted exercised during lapsing during of options as at price on date price on date Date of award 29 March 2009 during the year the year the year 28 March 2010 of award of exercise Note R M Steeves 26.6.
2009 50,339 50,339 504.5p 5 Notes: 1 As reported last year, these shares vested but 43,658 of them could not be exercised until 29 July 2009.
2 A second conditional award was made on 26 June 2006 over shares that have a value of 150% of the relevant directors salary.
The measurement period for this award runs from this date to 26 June 2009.
3 A third award was made on 12 June 2007 over shares that have a value of 150% of the relevant directors salary.
The measurement period for this award runs from this date to 12 June 2010.
4 A fourth award was made on 30 June 2008 over shares that have a value of 200% of the salary of R M Steeves and 150% of the salary of I M Jacques and M L M Smit.
The measurement period for this award runs from this date to 30 June 2011.
5 A fifth award was made on 14 July 2009 over shares that have a value of 150% of the salary of R M Steeves and 125% of the salary of I M Jacques and M L M Smit.
The measurement period for this award runs from this date to 14 July 2012.
6 On 31 March 2010, R M Steeves exercised 16,310 and I M Jacques exercised 10,221 of these shares under the revised LTIP arrangements referred to earlier.
Synergy Health plc 50 Annual Report & Financial Statements 2010 Remuneration report continued b LTIP co-invest Maximum number Maximum number Number of Number of Maximum number of matching of matching matching options matching options of matching Price paid by Mid-market options as at options granted exercised during lapsing during options as at Director for price on date Date of award 29 March 2009 during the year the year the year 28 March 2010 co-invest shares of exercise Note R M Steeves 26.6.
2009 3,000 3,000 510.0p Notes 1 The actual number of matching shares that will vest is contingent on the performance targets described earlier.
2 On 31 March 2010, R M Steeves exercised 36,500 and I M Jacques exercised 5,000 of these shares under the revised LTIP arrangements referred to earlier.
The market price of the 0.625p ordinary shares was 612.5p at 28 March 2010.
The market price ranged from 303.25p to 680p during the year.
Synergy Health plc 51 Annual Report & Financial Statements 2010 Performance graph The graph below shows the Groups performance for the five-year period to 28 March 2010 measured by total shareholder return TSR, compared with the performance of the FTSE Small Cap index excluding investment trusts also measured by TSR, which is fide ned as share price growth plus reinvested dividends.
The FTSE Small Cap index has been chosen because it provides a basis for comparison against companies in a relevant broadbased equity index in which the Group would have been a constituent member if it had been on the full list of the London Stock Exchange for the whole measurement period.
900 800 700 600 500 400 300 200 100 0 Apr-05 Oct-05 Apr-06 Oct-06 Apr-07 Oct-07 Apr-07 Oct-07 Apr-08 Oct-08 Apr-09 Oct-09 Mar-10 Synergy Health FTSE Small Cap Index excluding Investment Trusts rebased Source: Datastream D K Nichol Chairman of the Remuneration Committee Share Price p
